Skip to main content
TipRanks
Go Ultimate75% OFF

Greenlight Capital Re (G8L) AI Stock Analysis

0 Followers
DE:G8L

Greenlight Capital Re

(Frankfurt:G8L)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Very Low LeverageAn effectively debt-free balance sheet gives Greenlight Re substantial financial flexibility across reinsurance cycles. Low leverage reduces interest and refinancing pressure, supports resilience when underwriting or investments weaken, and preserves capacity to deploy capital into attractive opportunities.
Negative Factors
Premium ContractionPremium contraction reduces the scale of the underwriting platform and can weaken earnings leverage if lower volume persists. Management is exercising prudent cycle management, but softer market conditions and reduced exposures may limit near-term revenue growth and make expansion more dependent on Innovation.

Greenlight Capital Re (G8L) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%50%DE:G8L+37.61%EWG+9.30%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 527.45M
Dividend Yield
―
Average Volume (3M)
409
Price to Earnings (P/E)
9.4
Beta (1Y)
-0.02
Revenue Growth
-7.63%
EPS Growth
22.86%
Country
Germany
Employees
84
Sector
Financial
Sector Strength
68
Industry
Insurance - Reinsurance

Greenlight Capital Re Business Overview & Revenue Model

Company Description

Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurance company worldwide. It operates through Open Market and Innovations segments. The company offers casualty reinsurance, such as automobile liability...

Greenlight Capital Re Earnings Call Summary

Earnings Call Date:Nov 02, 2026(Q3-2026)|% Change Since:15.38%|Next Earnings Date:Mar 10, 2027
Earnings Call SentimentNeutral

The call was explicitly described as mixed. Underwriting profitability, Innovation premium growth, reserve reductions, strategic partnerships, book value growth, and share repurchases were positive, while the Solasglas investment loss, open market premium contraction, adverse reserve development, higher open market ratios, and Innovation loss-ratio deterioration were notable challenges. Overall, the positive operating developments were offset by meaningful investment and reserve-related headwinds.

Positive Updates

Positive Net Income and Book Value Growth
Greenlight Re reported third-quarter net income of $3.2 million, or $0.10 per diluted share, bringing year-to-date net income to $9.4 million, or $0.28 per diluted share. Fully diluted book value per share increased 0.8% in the quarter to $20.78 and increased 1.7% during the first nine months of the year.

Negative Updates

Investment Portfolio Loss
The Solasglas portfolio declined 3.3% in the third quarter. The long portfolio detracted 7.6% and macro positions detracted 2.8%, partially offset by a 7.3% contribution from the short portfolio. This compared with a 2.3% advance in the S&P 500 during the quarter.

Company Guidance

For the 1/1 renewals, management said that while the market is continuing to soften, they generally believe that rates and terms remain attractive for the open market reinsurance business and expect to see profitable new opportunities through next year; Innovations’ growth continues to be strong with stable rates, and the company expects the segment’s expense ratio to decrease as it gains scale. Management also said it will continue to invest in Innovations to deliver profitable growth, with the Hippo partnership and Lloyd’s approval to transition Syndicate 3.46 thousand to a full syndicate expected to advance that objective, while $24.8 million remaining under the current Board approved repurchase plan will allow the company to continue repurchasing shares opportunistically; the agreement to repurchase 33% of the shares purchased on the open market from David will continue up to March 2027.

Greenlight Capital Re Risk Analysis

Greenlight Capital Re disclosed 2 risk factors in its most recent earnings report. Greenlight Capital Re reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Greenlight Capital Re Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

DE:G8L against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HGHG85Outperform$3.79B7.1623.92%―18.05%22.42%
SPNTSPNT80Outperform$2.98B6.2321.64%―18.14%163.19%
RGARGA78Outperform$17.45B10.3313.15%1.42%22.58%99.93%
RNRRNR76Outperform$14.23B10.0513.52%0.46%-21.18%-3.27%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
EGEG65Neutral$15.72B9.0512.52%1.88%-8.72%250.85%

* Financial Sector Average

Performance Comparison

0%20%40%60%DE:G8LEGRGARNRSPNTHGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:G8L and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:G8LGreenlight Capital Re15.003.7032.74%
EGEverest Group, Ltd.424.47126.7142.56%
RGAReinsurance Group Of America268.2986.4447.54%
RNRRenaissancere352.1892.1235.42%
SPNTSiriuspoint Ltd25.926.1731.24%
HGHamilton Insurance Group, Ltd. Class B38.4614.4159.89%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.